164 related articles for article (PubMed ID: 2410328)
1. Randomised controlled trial of adenine arabinoside 5'-monophosphate (ARA-AMP) in chronic hepatitis B virus infection.
Weller IV; Lok AS; Mindel A; Karayiannis P; Galpin S; Monjardino J; Sherlock S; Thomas HC
Gut; 1985 Jul; 26(7):745-51. PubMed ID: 2410328
[TBL] [Abstract][Full Text] [Related]
2. A randomised controlled trial of adenine arabinoside 5'-monophosphate (ARA-AMP) in chronic hepatitis B virus infection.
Weller IV
J Hepatol; 1986; 3 Suppl 2():S107-10. PubMed ID: 2439568
[TBL] [Abstract][Full Text] [Related]
3. Successful treatment of HBs and HBeAg positive chronic liver disease: prolonged inhibition of viral replication by highly soluble adenine arabinoside 5'-monophosphate (ARA-AMP).
Weller IV; Bassendine MF; Craxi A; Fowler MJ; Monjardino J; Thomas HC; Sherlock S
Gut; 1982 Sep; 23(9):717-23. PubMed ID: 6179819
[TBL] [Abstract][Full Text] [Related]
4. Differential effect of ARA-AMP on serum DNA polymerase activity and serum HBV-DNA in chronic hepatitis B virus infection. A possible reason for lack of efficacy.
Alexander GJ; Fagan EA; Rolando N; Guarner P; Callender ME; Eddleston AL; Williams R
J Hepatol; 1986; 3 Suppl 2():S81-6. PubMed ID: 2439580
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of hepatitis B virus replication by vidarabine monophosphate conjugated with lactosaminated serum albumin.
Fiume L; Cerenzia MR; Bonino F; Busi C; Mattioli A; Brunetto MR; Chiaberge E; Verme G
Lancet; 1988 Jul; 2(8601):13-5. PubMed ID: 2455204
[TBL] [Abstract][Full Text] [Related]
6. Prolonged inhibition of hepatitis B virus replication with vidarabine monophosphate in chronic active type B hepatitis.
Guardia J; Esteban R; Buti M; Jardí R; Allende H; Esteban JI
Liver; 1986 Apr; 6(2):118-22. PubMed ID: 2426552
[TBL] [Abstract][Full Text] [Related]
7. A randomized study of the effects of adenine arabinoside 5'-monophosphate (short or long courses) and lymphoblastoid interferon on hepatitis B virus replication.
Lok AS; Novick DM; Karayiannis P; Dunk AA; Sherlock S; Thomas HC
Hepatology; 1985; 5(6):1132-8. PubMed ID: 2415436
[TBL] [Abstract][Full Text] [Related]
8. Randomized controlled trial of adenine arabinoside 5'-monophosphate in chronic active hepatitis B: comparison of the efficacy in heterosexual and homosexual patients.
Marcellin P; Ouzan D; Degos F; Brechot C; Metman EH; Degott C; Chevalier M; Berthelot P; Trepo C; Benhamou JP
Hepatology; 1989 Sep; 10(3):328-31. PubMed ID: 2474480
[TBL] [Abstract][Full Text] [Related]
9. Disappearance of serum hepatitis B virus DNA by polymerase chain reaction after adenine arabinoside 5'-monophosphate therapy in chronic hepatitis B.
Buti M; Rodriguez-Frias F; Genesca J; Arranz A; Jardi R; Esteban R; Guardia J
Liver; 1993 Jun; 13(3):136-40. PubMed ID: 7687734
[TBL] [Abstract][Full Text] [Related]
10. Adenine arabinoside 5'-monophosphate in patients with chronic hepatitis B: comparison of the efficacy in patients with high and low viral replication.
Marcellin P; Pouteau M; Loriot MA; Boyer N; Degos F; Calès P; Bettan L; Bacq Y; Coppére H; Grange JD
Gut; 1995 Mar; 36(3):422-6. PubMed ID: 7535285
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of adenine arabinoside 5'-monophosphate in kidney transplant recipients with chronic active hepatitis B.
Pol S; Saltiel C; Legendre C; Carnot F; Driss F; Berthelot P; Bréchot C; Ruet C; Kreis H
Nephrol Dial Transplant; 1994; 9(7):820-3. PubMed ID: 7526277
[TBL] [Abstract][Full Text] [Related]
12. Adenine arabinoside monophosphate (vidarabine phosphate) in combination with human leukocyte interferon in the treatment of chronic hepatitis B. A randomized, double-blinded, placebo-controlled trial.
Garcia G; Smith CI; Weissberg JI; Eisenberg M; Bissett J; Nair PV; Mastre B; Rosno S; Roskamp D; Waterman K
Ann Intern Med; 1987 Sep; 107(3):278-85. PubMed ID: 2441633
[TBL] [Abstract][Full Text] [Related]
13. Comparative efficacy of adenine arabinoside 5' monophosphate and prednisone withdrawal followed by adenine arabinoside 5' monophosphate in the treatment of chronic active hepatitis type B.
Perrillo RP; Regenstein FG; Bodicky CJ; Campbell CR; Sanders GE; Sunwoo YC
Gastroenterology; 1985 Mar; 88(3):780-6. PubMed ID: 2578421
[TBL] [Abstract][Full Text] [Related]
14. Therapy of chronic type B hepatitis with adenine arabinoside and adenine arabinoside monophosphate.
Hoofnagle JH
J Hepatol; 1986; 3 Suppl 2():S73-80. PubMed ID: 2439579
[TBL] [Abstract][Full Text] [Related]
15. Treatment of chronic type B hepatitis with multiple ten-day courses of adenine arabinoside monophosphate.
Hoofnagle JH; Davis GL; Hanson RG; Pappas SC; Peters MG; Avigan MI; Waggoner JG; Howard R; Jones EA; Straus SE
J Med Virol; 1985 Feb; 15(2):121-8. PubMed ID: 2579192
[TBL] [Abstract][Full Text] [Related]
16. Adenine arabinoside 5'-monophosphate treatment of chronic type B hepatitis.
Hoofnagle JH; Minuk GY; Dusheiko GM; Schafer DF; Johnson R; Straus S; Jones EA; Gerin JL; Ishak K
Hepatology; 1982; 2(6):784-8. PubMed ID: 6183183
[TBL] [Abstract][Full Text] [Related]
17. The use of corticosteroids in conjunction with antiviral therapy in chronic hepatitis B with ongoing viral replication.
Perrillo RP
J Hepatol; 1986; 3 Suppl 2():S57-64. PubMed ID: 2439577
[TBL] [Abstract][Full Text] [Related]
18. Histological improvement after anti-viral treatment for chronic hepatitis B virus infection.
Brook MG; Petrovic L; McDonald JA; Scheuer PJ; Thomas HC
J Hepatol; 1989 Mar; 8(2):218-25. PubMed ID: 2469711
[TBL] [Abstract][Full Text] [Related]
19. Randomized controlled trial of adenine arabinoside monophosphate for chronic type B hepatitis.
Hoofnagle JH; Hanson RG; Minuk GY; Pappas SC; Schafer DF; Dusheiko GM; Straus SE; Popper H; Jones EA
Gastroenterology; 1984 Jan; 86(1):150-7. PubMed ID: 6196251
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathological response of HBsAg-positive chronic active hepatitis to adenine arabinoside: lack of correlation with DNA polymerase response.
Liaw YF; Lin DY; Chen TJ; Chu CM; Sheen IS
Infection; 1984; 12(4):248-50. PubMed ID: 6490167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
